홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Diisopropylethylamine → HCID 86685777, 화합물

HRID 74822
노트
인쇄 미리보기

반응식

HRID 74822 반응식
[O:1]=[C:2]1[CH:6]=[CH:5][C:4](=[O:7])[N:3]1[CH2:8][CH2:9][CH2:10][CH2:11][C:12]([OH:14])=O.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C.FC(F)(F)C(O)=O.[CH3:55][NH:56][C:57]([CH3:105])([C:59]([NH:61][C@H:62]([C:66]([N:68]([C@@H:70]([C@@H:101]([CH3:104])[CH2:102][CH3:103])[C@H:71]([O:99][CH3:100])[CH2:72][C:73]([N:75]1[CH2:79][CH2:78][CH2:77][C@H:76]1[C@H:80]([O:97][CH3:98])[C@@H:81]([CH3:96])[C:82]([NH:84][C@H:85]([C:93]([OH:95])=[O:94])[CH2:86][C:87]1[CH:92]=[CH:91][CH:90]=[CH:89][CH:88]=1)=[O:83])=[O:74])[CH3:69])=[O:67])[CH:63]([CH3:65])[CH3:64])=[O:60])[CH3:58]>ClCCl.CS(C)=O.CN(C=O)C>[O:7]=[C:4]1[CH:5]=[CH:6][C:2](=[O:1])[N:3]1[CH2:8][CH2:9][CH2:10][CH2:11][C:12]([N:56]([CH3:55])[C:57]([CH3:105])([C:59]([NH:61][C@H:62]([C:66]([N:68]([C@@H:70]([C@@H:101]([CH3:104])[CH2:102][CH3:103])[C@H:71]([O:99][CH3:100])[CH2:72][C:73]([N:75]1[CH2:79][CH2:78][CH2:77][C@H:76]1[C@H:80]([O:97][CH3:98])[C@@H:81]([CH3:96])[C:82]([NH:84][C@H:85]([C:93]([OH:95])=[O:94])[CH2:86][C:87]1[CH:92]=[CH:91][CH:90]=[CH:89][CH:88]=1)=[O:83])=[O:74])[CH3:69])=[O:67])[CH:63]([CH3:64])[CH3:65])=[O:60])[CH3:58])=[O:14]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 4

HCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 232738725-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentanoic acidHCID 86685778N,2-dimethylalanyl-N-{(1S,2R)-4-{(2S)-2-[(1R,2R)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl}-N-methyl-L-valinamide-trifluoroacetic acid salt

생성물 1

HCID 86685777HCID 86685777, 화합물수율 3.3%

시약·촉매·용매 3

HCID 679Dimethyl Sulfoxide용매HCID 6228Dimethylformamide용매2회HCID 6344Dichloromethane용매2회

실험 절차

To a stirring solution of 5-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentanoic acid (12 mg, 0.061 mM) in 0.4 mL of dichloromethane, and 0.1 mL of DMF, HATU (23.2 mg, 0.061 mM) was added followed by Hunig's base (0.033 mL, 0.188 mM). The reaction was allowed to stir for 5 minutes before #115 (39 mg, 0.047 mM) was added as a solution in 0.4 mL of dichloromethane, and 0.1 mL of DMF. The reaction was allowed to stir at room temperature for 3 hours and 15 minutes before being quenched through the addition of water containing a small amount of TFA. Reaction was then reduced down. Crude material was dissolved with DMSO and purified by reverse phase chromatography (Method J). The appropriate fractions were concentrated then (Genevac). Material was then further purified by reverse phase chromatography (Method K) with the appropriate fractions being concentrated (Genevac). Material was then transferred to a small vial using dichloromethane and methanol before being reduced down (Genevac) to afford mv#115 (1.4 mg, 3.3%) oil/solid mix. HPLC (Protocol A at 45° C.): m/z 897.5 [M+H+], retention time=9.149 minutes (purity >97%).

후처리

  1. custombefore being quenched through the addition of water containing a small amount of TFA
  2. customReaction
  3. custompurified by reverse phase chromatography (Method J)
  4. concentrationThe appropriate fractions were concentrated
  5. customMaterial was then further purified by reverse phase chromatography (Method K) with the appropriate fractions
  6. concentrationbeing concentrated (Genevac)

출처 및 근거

ORD 기록
ord-4816497456ca46f9a2fe9bd4f1a522b9
출처 데이터셋
uspto-grants-2014_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08828401B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트